Ligand Pharma (LGND) Tops Q4 EPS by 1c, Offers Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. DOX
4. VRTX
5. CHKP
6. CRWD
7. ON
8. INSP
9. CVI
10. HNGE

Go back to Ligand Pharma (LGND) Tops Q4 EPS by 1c, Offers Guidance

Ligand Reports Fourth Quarter and Full Year 2015 Financial Results

February 10, 2016 4:01 PM EST

Conference Call Begins at 4:30 p.m. Eastern Time Today

SAN DIEGO--(BUSINESS WIRE)-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three and 12 months ended December 31, 2015, and provided an operating forecast and program updates.

Financial highlights for the 2015 fourth quarter include:

Fourth quarter total revenues were $21.2 million and royalty revenues were $11.5 million. Fourth quarter adjusted EPS was $0.66 and GAAP EPS was $0.29. Fourth quarter cash flow from operations was $13.7 million.

A description of adjusted... More